What is the recommended diagnostic workup and treatment strategy for a patient with suspected inflammatory bowel disease presenting with severe colitis?

Management of Suspected IBD with Severe Colitis

Patients with suspected inflammatory bowel disease presenting with severe colitis require immediate hospitalization with joint management by a gastroenterologist and colorectal surgeon, initiation of intravenous corticosteroids (hydrocortisone 400 mg/day or methylprednisolone 60 mg/day), and intensive monitoring to prevent mortality from complications like toxic megacolon or perforation 1.

Immediate Diagnostic Workup

Clinical Assessment

Upon presentation, establish severity using Truelove and Witts' criteria which defines severe colitis as:

• Stool frequency ≥6 bloody stools per day
• Plus systemic toxicity (fever >37.8°C, tachycardia >90 bpm, anemia with hemoglobin <10.5 g/dL, or ESR >30 mm/hr)

Daily physical examination is mandatory to assess for abdominal tenderness and rebound tenderness, which may indicate impending perforation 1.

Laboratory Monitoring

Obtain the following every 24-48 hours 1:

• Complete blood count (CBC), ESR or CRP
• Serum electrolytes and albumin
• Liver function tests
• Fecal calprotectin has 88% sensitivity and 92% specificity for IBD at cutoff >50 μg/g 2

Imaging Studies

• Plain abdominal radiograph daily if colonic dilatation (transverse colon >5.5 cm) detected at presentation 1
• Low threshold for repeat imaging if clinical deterioration occurs
• CT scanning is preferred for acute abdominal symptoms; look for mean wall thickness of 8 mm (versus normal 2-3 mm) 3

Endoscopic Evaluation

Sigmoidoscopy should be performed to confirm diagnosis and assess severity, but full colonoscopy should be deferred in severe colitis due to perforation risk 1. Key findings distinguishing UC from CD:

• UC: Continuous inflammation from rectum proximally, granularity, loss of vascular pattern, friability, superficial ulcerations
• CD: Skip lesions, rectal sparing, deep/serpiginous ulcers, cobblestoning 2

Important caveat: Do not delay corticosteroid treatment waiting for stool microbiology results to exclude infection 1.

Initial Treatment Strategy

Immediate Interventions

Initiate the following simultaneously 1:

1. Intravenous corticosteroids: Hydrocortisone 400 mg/day OR methylprednisolone 60 mg/day (Grade B evidence)

   • Consider adding IV metronidazole as it may be difficult to distinguish active disease from septic complications 1

2. Supportive care:

   • IV fluid and electrolyte replacement to correct dehydration
   • Blood transfusion to maintain hemoglobin >10 g/dL 1
   • Subcutaneous heparin for thromboembolism prophylaxis (Grade B) 1
   • Nutritional support (enteral or parenteral) if malnourished (Grade C) 1

3. Monitoring protocol:

   • Vital signs four times daily (more frequently if deteriorating) 1
   • Stool chart documenting frequency, character, and blood presence 1

Patient Communication

Inform patients of 25-30% chance of requiring colectomy during this admission 1. This transparent discussion is essential for shared decision-making.

Treatment Response Assessment

Timeline for Decision-Making

• Assess response to IV corticosteroids at 5-7 days 4
• Monitor pulse rate, stool frequency, CRP, and plain abdominal radiograph to identify patients needing colectomy 1

Second-Line Medical Therapy

If no response after 5-7 days of IV corticosteroids:

• Cyclosporin 2 mg/kg/day can be initiated (requires specific precautions and surveillance) 5, 4
• Alternatively, infliximab 5 mg/kg is effective (Grade A) 1

Critical point: If cyclosporin is not used and patient fails IV steroids, colectomy should be performed immediately 4.

Surgical Indications

Emergency Surgery Required For:

• Refractory toxic megacolon
• Colonic perforation
• Severe colorectal bleeding 3
• Significant deterioration at any point during medical therapy 4

Surgical Approach

Subtotal colectomy with proximal ileostomy and rectosigmoid mucous fistula is the preferred procedure as it:

• Minimizes septic complications
• Preserves options for later intestinal continuity restoration 5

Common Pitfalls to Avoid

1. Delaying corticosteroids while awaiting stool cultures—infection can be treated concurrently if identified 1

2. Performing full colonoscopy in severe colitis—use sigmoidoscopy only to minimize perforation risk

3. Inadequate monitoring frequency—vital signs must be checked at least four times daily, not just once or twice 1

4. Missing colonic dilatation—failure to obtain daily abdominal radiographs when indicated can miss toxic megacolon

5. Prolonging failed medical therapy—if no response to IV steroids by 5-7 days, escalate to second-line therapy or surgery rather than continuing ineffective treatment 4

6. Inadequate thromboprophylaxis—IBD patients with severe colitis have high thromboembolism risk; subcutaneous heparin is mandatory 1

Distinguishing UC from CD in Severe Colitis

While definitive classification may not always be possible initially, consider:

• Imaging with intestinal ultrasound or MRE should be performed alongside colonoscopy for initial diagnosis 2
• For CD specifically: IV steroids remain appropriate for severe disease, with concomitant IV metronidazole often advisable 1
• The diagnostic workup and acute management principles are similar regardless of final classification

The evidence strongly supports this aggressive, multidisciplinary approach with close surgical collaboration from admission, as severe colitis carries significant mortality risk without prompt, intensive intervention 1, 6.